Published in Planta Med on December 01, 1983
Thuja occidentalis (Arbor vitae): A Review of its Pharmaceutical, Pharmacological and Clinical Properties. Evid Based Complement Alternat Med (2005) 1.19
Metabolism of Monoterpenes in Cell Cultures of Common Sage (Salvia officinalis) : Biochemical Rationale for the Lack of Monoterpene Accumulation. Plant Physiol (1990) 0.87
Thujone-Rich Fraction of Thuja occidentalis Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells. Evid Based Complement Alternat Med (2011) 0.79
Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem (2001) 7.03
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13
Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med (1994) 3.42
Turnover of carbon isotopes in tail hair and breath CO2 of horses fed an isotopically varied diet. Oecologia (2004) 3.14
Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J Antibiot (Tokyo) (1996) 2.22
Molecular genetic evidence for early evolutionary origin of budding peptidoglycan-less eubacteria. Nature (1984) 2.05
Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain (2000) 2.04
HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med (1996) 1.99
Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res (1989) 1.97
Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics (1998) 1.77
Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J (1996) 1.74
Four new bioactive manzamine-type alkaloids from the Philippine marine sponge Xestospongia ashmorica. J Nat Prod (1996) 1.70
New onset hypertension after extracorporeal shock wave lithotripsy: age related incidence and prediction by intrarenal resistive index. J Urol (1997) 1.70
Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Latissimus dorsi myocutaneous flap reconstruction of neck and axillary burn contractures. Plast Reconstr Surg (2000) 1.61
Asbestos exposure and gastrointestinal malignancy review and meta-analysis. Am J Ind Med (1988) 1.60
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60
DNA analysis in juvenile Huntington disease. Eur J Pediatr (1989) 1.58
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med (1999) 1.58
The utility of preoperative electrocardiograms in the ambulatory surgical patient. Arch Intern Med (1992) 1.58
Reporting the findings of clinical trials: a discussion paper. Bull World Health Organ (2008) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Characterization of a new lipopeptide surfactant produced by thermotolerant and halotolerant subsurface Bacillus licheniformis BAS50. Appl Environ Microbiol (1995) 1.54
A follow-up report of occupational stress in urban EMT-paramedics. Ann Emerg Med (1989) 1.54
Prospective comparison of panoramic tomography (zonography) and helical computed tomography in the diagnosis and operative management of mandibular fractures. Plast Reconstr Surg (2001) 1.53
The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity (1999) 1.50
Myxochelin A, a new iron-chelating compound from Angiococcus disciformis (Myxobacterales). Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (1989) 1.49
New lessons for combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J Biol Chem (1999) 1.49
A follow-up study of gastro-intestinal diseases related to bacteriologically substandard drinking water. Am J Public Health (1987) 1.48
Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol (2001) 1.47
Parents of Children with Asperger Syndrome: What is the Cognitive Phenotype? J Cogn Neurosci (1997) 1.44
The validity of self-reported oral health status in the elderly. J Public Health Dent (1991) 1.44
Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J (1988) 1.43
Qualitative and Quantitative Analysis of the Phenolic Constituents from Orthosiphon aristatus. Planta Med (1991) 1.38
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37
Optimized expression of green fluorescent protein in Toxoplasma gondii using thermostable green fluorescent protein mutants. Mol Biochem Parasitol (2001) 1.35
A 31P-nuclear-magnetic-resonance study of the phosphate groups in lipopolysaccharide and lipid A from Salmonella. Eur J Biochem (1977) 1.34
A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem (2001) 1.30
Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry (1996) 1.29
Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol (1998) 1.28
The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo) (1987) 1.28
Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infect Immun (1998) 1.26
Evidence for distinct amino acid transport systems in cultured tobacco cells. Z Naturforsch C (1979) 1.25
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). J Antibiot (Tokyo) (1983) 1.22
Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase. Eur J Biochem (1994) 1.21
Subcellular localization of myosin V in nerve growth cones and outgrowth from dilute-lethal neurons. J Cell Sci (1997) 1.21
The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J Antibiot (Tokyo) (1985) 1.20
Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J Cell Biol (1998) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Antibiotic and cytotoxic activity of brominated compounds from the marine sponge Verongia aerophoba. Z Naturforsch C (1994) 1.18
Chemical and physical characterization of four interfacial-active rhamnolipids from Pseudomonas spec. DSM 2874 grown on n-alkanes. Z Naturforsch C (1985) 1.18
Musculoskeletal impairments and physical disablement among the aged. J Gerontol (1990) 1.17
New macrolides and furan carboxylic acid derivative from the sponge-derived fungus Cladosporium herbarum. J Nat Prod (2001) 1.16
Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg (2001) 1.16
Initial reactions in the biodegradation of 1-chloro-4-nitrobenzene by a newly isolated bacterium, strain LW1. Appl Environ Microbiol (1999) 1.15
Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J Biol Chem (2000) 1.15
Levels of a terpenoid glycoside (blumenin) and cell wall-bound phenolics in some cereal mycorrhizas. Plant Physiol (1995) 1.14
Structure of an acidic exopolysaccharide of Burkholderia pseudomallei. Eur J Biochem (1997) 1.14
Amino acid uptake by amino acid analog resistant tobacco cell lines. Z Naturforsch C (1979) 1.13
Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties. J Antibiot (Tokyo) (1995) 1.13
Phosphorus-31 nuclear magnetic resonance investigation of the in vivo regulation of intracellular pH in cell suspension cultures of Nicotiana tabacum: the effects of oxygen supply, nitrogen, and external pH change. Arch Biochem Biophys (1985) 1.13
Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause (2001) 1.12
The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo) (1995) 1.12
Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis (2010) 1.12
Silicone breast implants and immune disease. Ann Plast Surg (1992) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15. Eur J Biochem (2000) 1.09
A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J Exp Med (1997) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Simultaneous hypoglycemia and acute congestive heart failure. Circulation (1969) 1.09
Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther (2004) 1.08
Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). Int J Pept Protein Res (1996) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
New natural products from the sponge-derived fungus Aspergillus niger. J Nat Prod (2004) 1.08
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
When is treatment for cancer economically justified? J R Soc Med (1990) 1.07
Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol (1996) 1.07
Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes (2000) 1.06
Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (2000) 1.06
Survey of children supported by long-term mechanical ventilation in Switzerland. Swiss Med Wkly (2001) 1.06
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer (1999) 1.04
Rapid epitope identification from complex class-II-restricted T-cell antigens. Trends Immunol (2001) 1.04
Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). II. structure elucidation. J Antibiot (Tokyo) (1980) 1.02
Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (1994) 1.01
Biologically active secondary metabolites from myxobacteria. Biotechnol Adv (1993) 1.01
Pancreatic cancer treatment and research: an international expert panel discussion. Ann Oncol (2011) 1.01
Formation and identification of interfacial-active glycolipids from resting microbial cells. Appl Environ Microbiol (1984) 1.01
3-nitroadipate, a metabolic intermediate for mineralization of 2, 4-dinitrophenol by a new strain of a Rhodococcus species. J Bacteriol (1999) 1.01
HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int (1995) 1.01
Four new bioactive polybrominated diphenyl ethers of the sponge Dysidea herbacea from West Sumatra, Indonesia. J Nat Prod (1997) 1.01
Management of acute bronchiolitis: can evidence based guidelines alter clinical practice? Thorax (2008) 1.01